Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EASL position paper on clinical follow-up after HCV cure
Thomas Reiberger, Sabela Lens, Giuseppe Cabibbo, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 2, pp. 326-344
Closed Access | Times Cited: 22

Showing 22 citing articles:

Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis
Pierre Nahon, Clovis Lusivika‐Nzinga, Philippe Merle, et al.
Journal of Hepatology (2025)
Closed Access | Times Cited: 1
Recompensation of decompensated cirrhosis in hepatitis C patients after SVR: Prognostic implications
Yolanda Sánchez‐Torrijos, Paula Álvarez, José Miguel Rosales Zábal, et al.
Journal of Hepatology (2025)
Closed Access | Times Cited: 1
A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs)
Lorenza Di Marco, Simona Cannova, Emanuele Ferrigno, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 163-163
Open Access
Response to: Unlock AI-Safe-C score's potential at all levels: Improve methods and overcome barriers
Huapeng Lin, Terry Cheuk‐Fung Yip, Vincent Wai‐Sun Wong, et al.
Journal of Hepatology (2025)
Closed Access
Long‐Term Liver Morbidity and Mortality After Hepatitis C Virus Elimination by Direct‐Acting Antivirals
Eiichi Ogawa, Akira Kawano, Motoyuki Kohjima, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access
The clinical challenge of managing patients after sustained virological response with direct-acting antivirals for Hepatitis C
Anna Pocurull, Sabela Lens
Current Opinion in Gastroenterology (2025)
Closed Access
Surveillance in HCC: Making the Most of What We Have Today
Marco Sanduzzi‐Zamparelli, Giuseppe Cabibbo
Liver International (2025) Vol. 45, Iss. 4
Closed Access
Future of Endoscopy in Surveillance of Esophageal Varices
Carlos Moctezuma‐Velázquez, Juan Abraldes
Current Gastroenterology Reports (2025) Vol. 27, Iss. 1
Closed Access
Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study)
Chung-Feng Huang, Jeong Heo, Rong-Nan Chien, et al.
Infectious Diseases and Therapy (2025)
Open Access
Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma
Lorraine Blaise, Marianne Ziol, Claudia Campani, et al.
JHEP Reports (2025), pp. 101430-101430
Open Access
Reply to comment on “Posttreatment FIB-4 score change predicts hepatocellular carcinoma in chronic hepatitis C patients: Findings from the Taiwan hepatitis C registry program”
Hung‐Wei Wang, Cheng‐Yuan Peng, Ming‐Lung Yu
Journal of the Formosan Medical Association (2025)
Open Access
Updated recommendations for the management of hepatitis B, C, and E virus infections in patients with haematological malignancies and those undergoing haematopoietic cell transplantation: recommendations from the 9th European Conference on Infections in Leukaemia (ECIL-9)
Małgorzata Mikulska, Florian van Bömmel, Charlotte Mouliade, et al.
The Lancet Haematology (2025) Vol. 12, Iss. 5, pp. e389-e399
Closed Access
Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: A public health approach for effective preventive hepatology
Dana Ivancovsky‐Wajcman, Aina Nicolàs, Camila A. Picchio, et al.
JHEP Reports (2025), pp. 101436-101436
Open Access
AI-Safe-C Score: Assessing Liver-Related Event Risks in Non-Cirrhotic Patients after Successful Direct-Acting Antiviral Treatment
Huapeng Lin, Terry Cheuk‐Fung Yip, Hye Won Lee, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 3
Liver stiffness as a dynamic predictor of decompensation and mortality in alcohol-related liver disease
Majeed M. A. Ali
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 3
MASLD after hepatitis C virus eradication: Do not overlook the cardiometabolic risk factors
Rex Wan‐Hin Hui, Lung‐Yi Mak
Clinical and Molecular Hepatology (2024) Vol. 31, Iss. 1, pp. 290-292
Open Access | Times Cited: 1
Follow‐up post‐HCV virological response to DAA in advanced chronic liver disease
A. Romano, N. Zeni, A.R. Caspanello, et al.
Liver International (2024)
Closed Access | Times Cited: 1
Mechanisms and implications of recompensation in cirrhosis
Salvatore Piano, Thomas Reiberger, Jackie Bosch
JHEP Reports (2024) Vol. 6, Iss. 12, pp. 101233-101233
Open Access | Times Cited: 1
Non-invasive assessment of portal hypertension: Liver stiffness and beyond
Mattias Mandorfer, Juan Abraldes, Annalisa Berzigotti
JHEP Reports (2024) Vol. 7, Iss. 3, pp. 101300-101300
Closed Access | Times Cited: 1
Impact of Treatment with Direct Antivirals on Coagulation Parameters in Patients with HCV-related Liver Cirrhosis and Sustained Virological Response
Laura Huiban, Carol Stanciu, Cristina Muzîca, et al.
(2024)
Open Access
Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?
Chung‐Feng Huang, Ming‐Lun Yeh, Chia‐Yen Dai, et al.
Clinical and Molecular Hepatology (2024)
Open Access
Impact of Treatment with Direct Antivirals on Coagulation Parameters in Patients with Hepatitis C Virus-Related Liver Cirrhosis and Sustained Virological Response
Laura Huiban, C Stanciu, Cristina Muzîca, et al.
Medicina (2024) Vol. 60, Iss. 9, pp. 1539-1539
Open Access
Communicable Episode 06: “Sneaky viruses”- an update on hepatitis B & C before World Hepatitis Day
Kathryn Hostettler, Mojca Matičič, Oana Săndulescu, et al.
CMI Communications (2024) Vol. 1, Iss. 3, pp. 105048-105048
Closed Access
How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023
Mojca Matičič, Jasna Černoša, C Loboda, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access
Page 1

Scroll to top